sanofi pasteur
 
Menactra® - Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diptheria Toxoid Conjugate Vaccine Logo
Canadian visitors please visit
menactra.ca
 

Welcome to Menactra.com!

Your on-line resource for the prevention of meningococcal disease

Because adolescents are at increased risk
for meningococcal disease,
health-care professionals should take
advantage of every opportunity to
talk to parents and their adolescent children
about the dangers of meningococcal disease
and the benefits of vaccination.

Order Menactra Vaccine - www.vaccineshoppe.com

CDC ACIP Recommendations
for Meningococcal
Vaccination

Centers for Disease Control and Prevention (CDC) has expanded the Advisory Committee on Immunization Practices' (ACIP) recommendations for routine vaccination of adolescents with the quadrivalent meningococcal conjugate vaccine.

Adolescents
Are at Increased Risk

Following childhood, meningococcal disease rates begin to rise again in early adolescence and peak between 15 and 24 years of age.

Health-Care Professional
In-Office Resources

The meningococcal vaccination Patient Call-Back System will help you and your staff keep track of the adolescents in your practice who need to be vaccinated in order to reduce the risk of meningococcal disease.